Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods

AIM: To evaluate the potential value of using a serological assay to quantitate the hepatitis C virus core antigen (HCV-Ag) when monitoring patients with chronic hepatitis C being treated with direct-acting antivirals (DAAs). METHODS: Ninety-six patients treated with DAAs, either alone (91) or in co...

Descripción completa

Detalles Bibliográficos
Autores principales: Loggi, Elisabetta, Galli, Silvia, Vitale, Giovanni, Di Donato, Roberto, Vukotic, Ranka, Grandini, Elena, Margotti, Marzia, Guarneri, Valeria, Furlini, Giuliano, Galli, Claudio, Re, Maria Carla, Andreone, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681287/
https://www.ncbi.nlm.nih.gov/pubmed/29125869
http://dx.doi.org/10.1371/journal.pone.0187755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681287/
https://www.ncbi.nlm.nih.gov/pubmed/29125869
http://dx.doi.org/10.1371/journal.pone.0187755

Ejemplares similares